"Graft vs Host Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.
| Descriptor ID |
D006086
|
| MeSH Number(s) |
C20.452
|
| Concept/Terms |
Graft vs Host Disease- Graft vs Host Disease
- Graft-Versus-Host Disease
- Disease, Graft-Versus-Host
- Diseases, Graft-Versus-Host
- Graft Versus Host Disease
- Graft-Versus-Host Diseases
- Runt Disease
- Disease, Runt
- Graft-vs-Host Disease
- Disease, Graft-vs-Host
- Diseases, Graft-vs-Host
- Graft-vs-Host Diseases
- Homologous Wasting Disease
- Disease, Homologous Wasting
|
Below are MeSH descriptors whose meaning is more general than "Graft vs Host Disease".
Below are MeSH descriptors whose meaning is more specific than "Graft vs Host Disease".
This graph shows the total number of publications written about "Graft vs Host Disease" by people in this website by year, and whether "Graft vs Host Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1997 | 1 | 1 | 2 |
| 1999 | 0 | 2 | 2 |
| 2000 | 1 | 1 | 2 |
| 2001 | 2 | 2 | 4 |
| 2002 | 5 | 3 | 8 |
| 2003 | 7 | 5 | 12 |
| 2004 | 4 | 1 | 5 |
| 2005 | 5 | 4 | 9 |
| 2006 | 5 | 3 | 8 |
| 2007 | 3 | 3 | 6 |
| 2008 | 9 | 6 | 15 |
| 2009 | 5 | 4 | 9 |
| 2010 | 11 | 4 | 15 |
| 2011 | 11 | 5 | 16 |
| 2012 | 13 | 3 | 16 |
| 2013 | 8 | 4 | 12 |
| 2014 | 15 | 8 | 23 |
| 2015 | 19 | 11 | 30 |
| 2016 | 10 | 9 | 19 |
| 2017 | 13 | 4 | 17 |
| 2018 | 18 | 8 | 26 |
| 2019 | 18 | 5 | 23 |
| 2020 | 23 | 3 | 26 |
| 2021 | 16 | 6 | 22 |
| 2022 | 23 | 0 | 23 |
| 2023 | 23 | 1 | 24 |
| 2024 | 14 | 4 | 18 |
| 2025 | 8 | 4 | 12 |
| 2026 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Graft vs Host Disease" by people in Profiles.
-
Fecal carbohydrate-degrading bacteria are associated with reduced incidence of lower gastrointestinal GVHD. Blood Adv. 2026 Mar 24; 10(6):1979-1991.
-
Risk biomarkers of chronic GVHD in children aged 10 years or younger and children/adults older than 10 years. Blood Adv. 2026 Jan 13; 10(1):168-180.
-
Mitochondrial complex II orchestrates divergent effects in CD4+ and CD8+ T cells. J Clin Invest. 2025 Dec 15; 135(24).
-
Inflammatory Markers and Microbiome Dysbiosis in Hematopoietic Cell Transplant Recipients with Lung Graft-versus-Host Disease. Transplant Cell Ther. 2025 Sep; 31(9):668.e1-668.e12.
-
Impact of Abatacept Inclusive Graft-Versus-Host Disease Prophylaxis in Pediatric Stem Cell Transplantation for Hemoglobinopathy. Transplant Cell Ther. 2025 Oct; 31(10):826.e1-826.e10.
-
Deficiency of T follicular helper cell Tet3 DNA demethylation inhibits pathogenic IgG2c class switching and chronic GVHD. Blood. 2025 Jun 12; 145(24):2813-2827.
-
Novel regulators of GVHD revealed through microbiome and metabolome patterns across distinct intestinal regions. Blood. 2025 Jun 05; 145(23):2774-2787.
-
Anti-viral CD8 central memory veto cells as a new platform for CAR T cell therapy. Stem Cells Transl Med. 2025 May 31; 14(6).
-
Dessicating stress triggers and exacerbates experimental ocular Graft-versus-host-disease. Ocul Surf. 2025 Jul; 37:236-246.
-
Fludarabine Plus Myeloablative Dose of Busulfan Regimen Was Associated with High Nonrelapse Mortality in Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Lymphoma: A Propensity Score-Matched Comparison Study with Fludarabine Plus High-Dose Melphalan. Transplant Cell Ther. 2025 Jun; 31(6):382.e1-382.e17.